Search results
Apr 23, 2024 · Dr. Amit G. Pandya is the Immediate Past-President and Medical Advisory Board Chair of the Global Vitiligo Foundation, and a dermatologist at the Palo Alto Medical Foundation in Sunnyvale, California.
Apr 6, 2021 · Amit G. Pandya, MD is Staff Dermatologist at Palo Alto Medical Foundation. He is also a Clinical Professor, Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, TX.
Name: Amit G. Pandya, MD, FAAD, Global Vitiligo Foundation President and Medical Advisory Board Chair. Affiliations and institution: Palo Alto Foundation Medical Group, Sunnyvale, California; Department of Dermatology – University of Texas Southwestern Medical Center, Dallas Texas.
Clinical Professor, Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas. As the new president, what is your vision for GVF? It is with great pleasure and excitement that I begin my term as president of the Global Vitiligo Foundation.
May 15, 2023 · Amit Pandya, MD, FAAD, a dermatologist in Sunnyvale, California, the president of the Global Vitiligo Foundation, and director of the pigmentary disorders clinic at the Palo Alto Medical Foundation, spoke with Dermatology Times® to review his session, “Vitiligo Medical Treatment Advances,” as well as important topics from the meeting that ...
Amit PANDYA, Clinical Professor | Cited by 8,879 | of University of Texas Southwestern Medical Center, Texas (UT Southwestern) | Read 235 publications | Contact Amit PANDYA
May 9, 2022 · Amit G. Pandya, M.D., Medical Advisory Board Chair of the Global Vitiligo Foundation is a dermatologist at the Palo Alto Medical Foundation in Mountain View, California. Learn more about him here.
Amit G. Pandya. 400 color photos of skin disorders important in the treatment of patients with skin of color. Condensed information including epidemiology, etiology, clinical presentation and recognized treatment of the various skin disorders.
Jun 23, 2023 · Amit Pandya, MD: Ruxolitinib Cream in Real-World Vitiligo Patients of Color. June 23, 2023. By Kevin Kunzmann. Video. Conference | Maui Derm Conferences. The trial investigator reviews disparities in patient needs and treatment outcomes based on their skin complexion, 1 year after ruxolitinib's FDA approval.
Mar 28, 2022 · Amit G. Pandya, MD, FAAD, president of the Global Vitiligo Foundation in Chicago, delivered the Clarence S. Livingood, MD, Memorial Award and Lectureship during the Sunday P151 – Plenary.
